Stockwell Lynn's Form 4 filing
Drugs Made In America Acquisition Corp. (DMAA) · filed Feb 4, 2025
- Accession no.
- 0001213900-25-010193
- Filed
- Feb 4, 2025
- Trade date
- Jan 29, 2025
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stockwell LynnCIK 0001927032 | Director, Officer (CEO and Executive COB), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | Ordinary shares | PPurchaseAcquired | +400,000 | – | – | 10,257.14 | Indirect | |
| Jan 29, 2025 | Ordinary shares | JOtherDisposed | −400,000 | – | – | 9,857,143 | Indirect | |
| Jan 29, 2025 | Ordinary shares | SSaleDisposed | −5,698,363 | – | – | 4,158,780 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | Ordinary shares | PPurchaseAcquired | +400,000 | – | – | 400,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.